Cobicistat Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 4 pharmaceutical companies such as GILEAD SCIENCES INC, JANSSEN PRODS, BRISTOL and others. It is marketed under 7 brand names, including STRIBILD, TYBOST, PREZCOBIX and others. Available in 7 different strengths, such as 150MG;150MG;200MG;300MG, 150MG, 150MG;EQ 800MG BASE and others, and administered through 1 route including TABLET;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 4 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"37519","ingredient":"COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","trade_name":"GENVOYA","family_id":"0602d214c76a4d1d9d0b","publication_number":"US7390791B2","cleaned_patent_number":"7390791","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-07-07","publication_date":"2008-06-24","legal_status":"Expired"} US7390791B2 24 Jun, 2008 Expired 07 Jul, 2025
{"application_id":"93993","ingredient":"COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","trade_name":"GENVOYA","family_id":"e295e1cc478044948609","publication_number":"US7176220B2","cleaned_patent_number":"7176220","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-02-27","publication_date":"2007-02-13","legal_status":"Expired"} US7176220B2 13 Feb, 2007 Expired 27 Feb, 2027
{"application_id":"93943","ingredient":"COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","trade_name":"GENVOYA","family_id":"5d67bf920ac945649d75","publication_number":"US8981103B2","cleaned_patent_number":"8981103","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-04-26","publication_date":"2015-03-17","legal_status":"Granted"} US8981103B2 17 Mar, 2015 Granted 26 Apr, 2027
{"application_id":"93976","ingredient":"COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","trade_name":"GENVOYA","family_id":"5d67bf920ac945649d75","publication_number":"US7635704B2","cleaned_patent_number":"7635704","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-04-26","publication_date":"2009-12-22","legal_status":"Granted"} US7635704B2 22 Dec, 2009 Granted 26 Apr, 2027
{"application_id":"83141","ingredient":"COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","trade_name":"PREZCOBIX","family_id":"0509b810d9e84987b041","publication_number":"US7700645B2","cleaned_patent_number":"7700645","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-06-26","publication_date":"2010-04-20","legal_status":"Granted"} US7700645B2 20 Apr, 2010 Granted 26 Jun, 2027
{"application_id":"93517","ingredient":"COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","trade_name":"GENVOYA","family_id":"d62e2198e4184de59f06","publication_number":"US9891239B2","cleaned_patent_number":"9891239","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-03-03","publication_date":"2018-02-13","legal_status":"Granted"} US9891239B2 13 Feb, 2018 Granted 03 Mar, 2030
{"application_id":"93342","ingredient":"ATAZANAVIR SULFATE; COBICISTAT","trade_name":"EVOTAZ","family_id":"d62e2198e4184de59f06","publication_number":"US8148374B2","cleaned_patent_number":"8148374","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-03-03","publication_date":"2012-04-03","legal_status":"Court proceedings terminated"} US8148374B2 03 Apr, 2012 Court proceedings terminated 03 Mar, 2030
{"application_id":"93984","ingredient":"COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","trade_name":"GENVOYA","family_id":"4084a911ad2b4a4e8c46","publication_number":"US8633219B2","cleaned_patent_number":"8633219","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-30","publication_date":"2014-01-21","legal_status":"Granted"} US8633219B2 21 Jan, 2014 Granted 30 Oct, 2030
{"application_id":"91044","ingredient":"COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","trade_name":"GENVOYA","family_id":"edf7e71302324e0ea5cb","publication_number":"US8754065B2","cleaned_patent_number":"8754065","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-02-15","publication_date":"2014-06-17","legal_status":"Granted"} US8754065B2 17 Jun, 2014 Granted 15 Feb, 2033
{"application_id":"90997","ingredient":"COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","trade_name":"GENVOYA","family_id":"edf7e71302324e0ea5cb","publication_number":"US9296769B2","cleaned_patent_number":"9296769","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-02-15","publication_date":"2016-03-29","legal_status":"Granted"} US9296769B2 29 Mar, 2016 Granted 15 Feb, 2033
{"application_id":"93538","ingredient":"ATAZANAVIR SULFATE; COBICISTAT","trade_name":"EVOTAZ","family_id":"373fcc6058714641968b","publication_number":"US10039718B2","cleaned_patent_number":"10039718","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-04-06","publication_date":"2018-08-07","legal_status":"Granted"} US10039718B2 07 Aug, 2018 Granted 06 Apr, 2033
{"application_id":"100029","ingredient":"COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE","trade_name":"SYMTUZA","family_id":"a3189cee52ba4702bef7","publication_number":"US10786518B2","cleaned_patent_number":"10786518","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-07-19","publication_date":"2020-09-29","legal_status":"Granted"} US10786518B2 29 Sep, 2020 Granted 19 Jul, 2038

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Cobicistat

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.